AngioDynamics launches hemodialysis access catheter

AngioDynamics, a provider of medical devices for the treatment of peripheral vascular disease, has launched Centros, a self-centering, tunneled hemodialysis access catheter.

The Queensbury, N.Y.-based company said its distal end of the catheter has a curved configuration. Placed in the superior vena cava (SVC), its curved tips keep the ports of the catheter centered in the SVC, away from the vein walls. The tips of the catheter are not placed in the atrium, but in the lower third of the SVC, according to AngioDynamics.

AngioDynamics said it acquired worldwide rights to manufacture and market the Centros dialysis catheter from Lafayette, Indiana-based Ash Access Technology, of which designer Stephen R. Ash, MD, is board chairman and director of R&D.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.